A novel anti-CTLA-4 nanobody-IL12 fusion protein in combination with a dendritic cell/tumour fusion cell vaccine enhances the antitumour activity of CD8+ T cells in solid tumours.

Autor: Jiang, Meng-jie1 (AUTHOR), Cui, Hao-peng1 (AUTHOR), Li, Ting-ting1 (AUTHOR), Yang, Xiao-mei2 (AUTHOR), Lu, Xiao-ling2 (AUTHOR) luxiaoling@gxmu.edu.cn, Liu, Ai-qun1 (AUTHOR) liuaiqun_2004@163.com
Zdroj: Journal of Nanobiotechnology. 10/19/2024, Vol. 22 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje